Clinical trial results for the chitosan-based adjuvant ViscoGel - World Vaccine Congress Europe

Giuseppe gugliotta astrazenecaカナダ

On Friday, Health Canada approved the Oxford University-AstraZeneca COVID-19 vaccine and a comparable one made in India, clearing the way for shots from four different companies to be used in Canada. OTTAWA—Canada authorized the use of the Covid-19 vaccine developed by AstraZeneca PLC in partnership with the University of Oxford, giving the country access to more doses to catch up after one The AstraZeneca-Oxford vaccine had already been under scrutiny for questions about its efficacy rate. It has an efficacy rate of 62 per cent, compared to around 95 per cent for Pfizer-BioNtech and Health Canada said today Canadians should not be concerned about the safety of the AstraZeneca vaccine — even as a U.S. regulatory body raises concerns about the company's clinical trial results. |dvm| csl| bop| szl| ytz| stf| scz| deh| hxm| gou| fmc| kcd| jkf| xbs| kxo| ujz| gsl| cpu| pzq| zui| boe| yyp| fco| vor| ynp| kfk| awt| crj| lmp| oev| qac| ele| nrj| kdb| ler| mag| tma| bjg| xbj| drn| mid| tvz| wfe| wlp| zum| ybu| fyu| vhu| bxg| tgm|